Ellis Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,912
| Closed | -$56K | – | 415 |
|
|
2022
Q3 | $56K | Buy |
1,912
+309
| +19% | +$9.05K | 0.02% | 376 |
|
|
2022
Q2 | $87K | Buy |
1,603
+19
| +1% | +$1.03K | 0.02% | 325 |
|
|
2022
Q1 | $86K | Sell |
1,584
-75
| -5% | -$4.07K | 0.02% | 341 |
|
|
2021
Q4 | $91K | Buy |
1,659
+1,078
| +186% | +$59.1K | 0.02% | 337 |
|
|
2021
Q3 | $27K | Buy |
581
+5
| +0.9% | +$232 | 0.01% | 475 |
|
|
2021
Q2 | $28K | Buy |
576
+6
| +1% | +$292 | 0.01% | 469 |
|
|
2021
Q1 | $25K | Sell |
570
-4
| -0.7% | -$175 | 0.01% | 472 |
|
|
2020
Q4 | $26K | Buy |
574
+13
| +2% | +$589 | 0.01% | 453 |
|
|
2020
Q3 | $26K | Buy |
561
+4
| +0.7% | +$185 | 0.01% | 443 |
|
|
2020
Q2 | $28K | Buy |
557
+6
| +1% | +$302 | 0.01% | 425 |
|
|
2020
Q1 | $25K | Buy |
551
+209
| +61% | +$9.48K | 0.01% | 379 |
|
|
2019
Q4 | $20K | Sell |
342
-476
| -58% | -$27.8K | 0.01% | 435 |
|
|
2019
Q3 | $43K | Buy |
818
+484
| +145% | +$25.4K | 0.02% | 358 |
|
|
2019
Q2 | $16K | Buy |
+334
| New | +$16K | 0.01% | 468 |
|